Evidence map›Paper›PMID 34281951›Full record

ArticleInternational journal of spine surgery2021

Single-Level Cervical Disc Replacement Using a PEEK-on-Ceramic Implant: Results of a Multicenter FDA IDE Trial With 24-Month Follow-up.

Richard D Guyer, Domagoj Coric, Pierce D Nunley, Rick C Sasso, Michael Musacchio, Hyun W Bae, John H Peloza, Donna D Ohnmeiss

Open access · diamondAbstract read
In one paragraph

Article in International journal of spine surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. The fragility index and reverse fragility index of FDA investigational device exemption trials in spinal fusion surgery: a systematic review.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Beyond the two-year trial: real-World failure mechanisms of the simplify cervical disc.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Richard D GuyerCenter for Disc Replacement at Texas Back Institute, Plano, Texas.
Domagoj CoricCarolina Neurosurgery and Spine Associates, Charlotte, North Carolina.
Pierce D NunleySpine Institute of Louisiana, Shreveport, Louisiana.
Rick C SassoIndiana Spine Group, Carmel, Indiana.
Michael MusacchioNorthShore University Health System, Evanston, Illinois.
Hyun W BaeThe Spine Institute, Los Angeles, California.
John H PelozaSteadman-Hawkins Clinic, Vail, Colorado.
Donna D OhnmeissCenter for Disc Replacement at Texas Back Institute, Plano, Texas.
Texas Back Institute · USCarolina Neurosurgery and Spine Associates · USIndiana Spine Group · USNorthShore University HealthSystem · USSpine Institute of Louisiana · USSteadman Clinic · USThe Spine Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany early cervical total disc replacements (TDRs) produced motion through a ball-and-socket action, with metal endplates articulating with a plastic core. Polyetheretherketone (PEEK) is used increasingly for spinal implants due to its mechanical properties and lack of artifacts on imaging. A TDR was designed with titanium-coated PEEK endplates and a ceramic core. The purpose of this study was to compare this TDR with anterior cervical discectomy and fusion (ACDF) to treat single-level cervical disc degeneration.

methodsThis was a prospective, nonrandomized, historically controlled, multicenter US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) trial. Patients received the PEEK-on-ceramic Simplify

resultsThe success rate was significantly greater in the TDR group vs the ACDF group (93.0% vs 73.6%;

conclusionsThe TDR had an acceptable safety profile and a significantly greater composite success rate than ACDF. These results support that the PEEK-on-ceramic TDR is a viable alternative to ACDF for single-level symptomatic disc degeneration. CLINICAL RELEVANCE: This study found that the PEEK-on-ceramic TDR is a viable treatment for symptoms related to cervical disc degeneration and offers similar or superior outcomes compared with fusion. LEVEL OF EVIDENCE: 2.

Indexed as

cervical spineclinical outcomedisc replacementFDA IDE trialPEEK-on-ceramic device

Identifiers

PMID34281951
PMCPMC8375704
OpenAlexW3183244082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.